Virtu Financial LLC Oncolytics Biotech Inc Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$0.99 - $1.24 $24,202 - $30,314	-24,447 Reduced 47.11%	27,442 $27,000
Q1 2024 May 20, 2024	BUY	$0.89 - $1.36 $46,181 - $70,569	51,889 New	51,889 $55,000
Q1 2023 May 01, 2023	SELL	$1.2 - $1.91 $2,442 - $3,886	-2,035 Reduced 8.16%	22,918 $28,000
Q4 2022 Feb 15, 2023	BUY	$1.17 - $2.12 $29,195 - $52,900	24,953 New	24,953 $41,000
Q3 2021 Nov 12, 2021	SELL	$1.93 - $2.77 $68,370 - $98,127	-35,425 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$2.6 - $4.64 $92,105 - $164,372	35,425 New	35,425 $98,000
Q1 2021 May 19, 2021	SELL	$2.32 - $4.11 $45,441 - $80,502	-19,587 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$1.71 - $4.03 $33,493 - $78,935	19,587 New	19,587 $47,000
Q3 2020 Dec 11, 2020	SELL	$1.58 - $2.15 $24,474 - $33,303	-15,490 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$1.33 - $2.76 $20,601 - $42,752	15,490 New	15,490 $29,000

1.18M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $49.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.